Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dimitrov

Showing results (291-300 of 442) with videos related to

Pageof 45
Sort By:
Journal of Medicinal Chemistry|November 3, 2021
Immune Modulating Antibody-Drug Conjugate (IM-ADC) for Cancer ImmunotherapyLei He, Liangliang Wang, Zhisong Wang, et al.
Virology|December 7, 2007
Functional studies of host-specific ephrin-B ligands as Henipavirus receptorsKatharine N Bossart, Mary Tachedjian, Jennifer A McEachern, et al.
Journal of Nephrology|September 15, 2004
Balkan endemic nephropathy and genetic variants of glutathione S-transferasesIrena E Andonova, Radoslava B Sarueva, Anelia D Horvath, et al.
Vaccine|September 25, 2003
Purified complexes of HIV-1 envelope glycoproteins with CD4 and CCR5(CXCR4): production, characterization and immunogenicityXiaodong Xiao, Sanjay Phogat, Yuuei Shu, et al.
Molecular Cancer Therapeutics|February 2, 2013
A human single-domain antibody elicits potent antitumor activity by targeting an epitope in mesothelin close to the cancer cell surfaceZhewei Tang, Mingqian Feng, Wei Gao, et al.
Cancer Letters|November 6, 2021
A highly-specific fully-human antibody and CAR-T cells targeting CD66e/CEACAM5 are cytotoxic for CD66e-expressing cancer cells in vitro and in vivoDu-San Baek, Ye-Jin Kim, Sandra Vergara, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2013
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinomaMingqian Feng, Wei Gao, Ruoqi Wang, et al.
Frontiers in Oncology|December 8, 2018
A Unique Human Immunoglobulin Heavy Chain Variable Domain-Only CD33 CAR for the Treatment of Acute Myeloid LeukemiaDina Schneider, Ying Xiong, Peirong Hu, et al.
SAR and QSAR in Environmental Research|July 27, 2007
A kinetic model for predicting biodegradationS Dimitrov, T Pavlov, D Nedelcheva, et al.
The Laryngoscope|January 23, 2014
In vivo optical imaging of folate receptor-β in head and neck squamous cell carcinomaJoel Y Sun, Jiayin Shen, Joel Thibodeaux, et al.
Pageof 45

Showing results (291-300 of 442) with videos related to

Sort By:
Pageof 45
Journal of Medicinal Chemistry|November 3, 2021
Immune Modulating Antibody-Drug Conjugate (IM-ADC) for Cancer ImmunotherapyLei He, Liangliang Wang, Zhisong Wang, et al.
Virology|December 7, 2007
Functional studies of host-specific ephrin-B ligands as Henipavirus receptorsKatharine N Bossart, Mary Tachedjian, Jennifer A McEachern, et al.
Journal of Nephrology|September 15, 2004
Balkan endemic nephropathy and genetic variants of glutathione S-transferasesIrena E Andonova, Radoslava B Sarueva, Anelia D Horvath, et al.
Vaccine|September 25, 2003
Purified complexes of HIV-1 envelope glycoproteins with CD4 and CCR5(CXCR4): production, characterization and immunogenicityXiaodong Xiao, Sanjay Phogat, Yuuei Shu, et al.
Molecular Cancer Therapeutics|February 2, 2013
A human single-domain antibody elicits potent antitumor activity by targeting an epitope in mesothelin close to the cancer cell surfaceZhewei Tang, Mingqian Feng, Wei Gao, et al.
Cancer Letters|November 6, 2021
A highly-specific fully-human antibody and CAR-T cells targeting CD66e/CEACAM5 are cytotoxic for CD66e-expressing cancer cells in vitro and in vivoDu-San Baek, Ye-Jin Kim, Sandra Vergara, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2013
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinomaMingqian Feng, Wei Gao, Ruoqi Wang, et al.
Frontiers in Oncology|December 8, 2018
A Unique Human Immunoglobulin Heavy Chain Variable Domain-Only CD33 CAR for the Treatment of Acute Myeloid LeukemiaDina Schneider, Ying Xiong, Peirong Hu, et al.
SAR and QSAR in Environmental Research|July 27, 2007
A kinetic model for predicting biodegradationS Dimitrov, T Pavlov, D Nedelcheva, et al.
The Laryngoscope|January 23, 2014
In vivo optical imaging of folate receptor-β in head and neck squamous cell carcinomaJoel Y Sun, Jiayin Shen, Joel Thibodeaux, et al.
Pageof 45